Dr Reddys Laboratories Share Price Today - Live Blog for April 30, 2025

Dr Reddys Laboratories Ltd stock price decreased by -0.37%, with the current market value at ₹1,179.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.31%, a situation worth noting. At present, the stock is trading at ₹1,181.60. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.2700, while the industry PE ratio is 34.8435.

Dr Reddys Laboratories Ltd observed a remarkable 0.04% surge in its share price and is presently trading at ₹1,185.35. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd share price has declined by -0.04%, and it's currently trading at ₹1,184.90. The stock maintains a PE of 18.2700, while the industry PE is 34.8435, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.33% increase and currently trading at ₹1,185.40 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's shares experienced a 0.19% uptick, and they are currently valued at ₹1,182.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd stock price decreased by -0.04%, with the current market value at ₹1,181.30 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,181.75, and market participants are assessing the implications. The stock has a PE ratio of 18.2700, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

With a remarkable 0.37% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,182.30. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.2700, while the industry's PE ratio is 34.8435.

The stock of Dr Reddys Laboratories Ltd suffered a -0.24% drop, and it's now trading at ₹1,179.70 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.01% in its share price, and it currently trades at ₹1,182.40 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price rallied by 0.12%, reaching the current market price of ₹1,182.90. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd plunged by -0.32%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,181.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price has declined by -0.05%, and it's currently trading at ₹1,185.35. The stock maintains a PE of 18.2700, while the industry PE is 34.8435, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is facing a -0.29% decline and is currently trading at ₹1,186.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.38% boost, with the current market value at ₹1,189.55 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.02% drop, and it's now trading at ₹1,186.25 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has fallen by -0.31%, a situation worth noting. At present, the stock is trading at ₹1,187.15. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.2700, while the industry PE ratio is 34.8435.

The stock of Dr Reddys Laboratories Ltd suffered a -0.14% drop, and it's now trading at ₹1,190.80 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.42% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,191.95 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd observed a -0.26% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,186.90. The stock has a PE ratio of 18.2700, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.20% gain, with the share price now at ₹1,190.05. Notably, the stock's PE ratio stands at 18.2700, and its Return on Equity (ROE) is 17.3623%.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.02% upswing, and it's currently trading at ₹1,186.40 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd witnessed a -0.49% decrease in its share price, and it is currently trading at ₹1,187.60. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.2700, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd experienced a substantial 0.23% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,193.65, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 1.15%, reaching the current market price of ₹1,189.80. This development underscores the stock's growing popularity.